FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/02/105086 [Registered on: 27/02/2026] Trial Registered Prospectively
Last Modified On: 25/02/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   To Study The Effect Of Kaishora Guggulu In Vatarakta (Gout) With Investigation Of Serum Uric Acid.  
Scientific Title of Study   Randomized controlled clinical trial to study effect of Kaishora Guggulu in vatarakta (Gout) with special reference to serum uric acid.  
Trial Acronym  vatarakta 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Snehal Uttamrao Ranvir  
Designation  PG scholar 
Affiliation  LRP Ayurvedic Medical College and Hospital, Post Graduate Institute and Research Center Islampur  
Address  LRP Ayurvedic Medical College and Hospital PG Institute and Research Centre Islampur, Department of Rognidan, Division No.1, Room no 1 tq. Walwa Dist. Sangli
LRP Ayurvedic Medical College and Hospital PG Institute and Research Centre Islampur, Department of Rognidan, Division No.1, Room no 1 tq. Walwa Dist. Sangli
Sangli
MAHARASHTRA
415409
India 
Phone  8552871321  
Fax    
Email  snehalranvir1995@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Gauri Atmaram Mulik  
Designation  Professor and HOD  
Affiliation  LRP Ayurvdic Medical College And Hospital Post Graduate Institute and Research Center Islampur  
Address  LRP Ayurvdic Medical College and Hospital, Post Graduate Institute and Research Center Islampur, Department of Rognidan, Islampur, Tal. Walwa, Dist. Sangli
LRP Ayurvdic Medical College and Hospital, Post Graduate Institute and Research Center Islampur, Department of Rognidan, Islampur, Tal. Walwa, Dist. Sangli
Sangli
MAHARASHTRA
415409
India 
Phone  8806073556  
Fax    
Email  gaurimohite492@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Gauri Atmaram Mulik  
Designation  Professor and HOD  
Affiliation  LRP Ayurvdic Medical College And Hospital ,Post Graduate Institute and Research Center Islampur  
Address  LRP Ayurvdic Medical College and Hospital, Post Graduate Institute and Research Center Islampur, Department of Rognidan, Islampur, Tal. Walwa, Dist. Sangli
LRP Ayurvdic Medical College and Hospital, Post Graduate Institute and Research Center Islampur, Department of Rognidan, Islampur, Tal. Walwa, Dist. Sangli
Sangli
MAHARASHTRA
415409
India 
Phone  8806073556  
Fax    
Email  gaurimohite492@gmail.com  
 
Source of Monetary or Material Support  
LRP Ayurvedic Medical College and Hospital PG Institute and Research Centre Islampur, Department of Rognidan, Division No.1, Room no 1 tq. Walwa Dist. Sangli Sangli MAHARASHTRA 415409 India 
 
Primary Sponsor  
Name  Dr Snehal Uttamrao Ranvir  
Address  LRP Ayurvedic Medical College and Hospital PG Institute and Research Centre Islampur, Department of Rognidan, Division No.1, Room no 1 tq. Walwa Dist. Sangli MAHARASHTRA 415409 India 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 0  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
LOKNETE RAJARAMBAPU PATIL AYURVEDA MAHAVIDYALAYA SANGLI INSTITUTIONAL ETHICAL COMMITTEE   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:PCS||. Ayurveda Condition: VATARAKTAM,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Kaishora Guggulu, Reference: Shanargdhar Samhita, nadhyam khanda , chapter 7, shloka 70 to 81, Route: Oral, Dosage Form: Guggulu , Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: koshna jala), Additional Information: Nil
2Comparator Arm (Non Ayurveda)-AllopurinolNil
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  patient having sing and symptoms such as Sandhishoola, Sprashasahatva,Sandhishotha
Stabdhata, Daha.
patient of either gender,irrespective of socioeconomic status
 
 
ExclusionCriteria 
Details  patient below 18 years and above 60 years old.
pregnant women and lactating mother.
knowncase of HIV.
knowncase Rheumatoid arthritis, Tubercular arthritis Syphilitic arthritis, Maleria, Neurological disorder.
knowncase of chikungunya
knowncase of erythematous.
serum uric acid level more than 12mg/dl.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
to study add on effect of kaishora guggulu in the management of vatarakta (gout) with special reference to serum uric acid   30 days 
 
Secondary Outcome  
Outcome  TimePoints 
1)To study vatarakta in detail according to ayurveda
2)To study gout in detail according to modern science
3) To study kaishora guggulu properties.
4)To study serum uric acid in
details.
5)To study effect of kaishora guggulu on sign & symptoms of vatarakta & on uric acid levels.  
18 months  
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   20/03/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  20/03/2026 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
vatarakta is disorder of VataDosha which is associated with DushyaRakta ,the chief complaint of patients is joint pain with onset from Hasta, Padangushtamulagata sandhi and then it migrates to other joints in a way similar to Akhuvisha.
the disease which is most commonly seen in kudhavata i.e near the ankle or in smaller joints. the classical symptoms include Shvayathu, Bheda, Toda, Shoola, Sparshasahatva considering, the clinical presentation and textualreferences of the disease it can correlated with  Gout explained in modern medicine 
Gout is the most Common type of inflammatory arthritis and is associated with impaired quality of life. the formation and deposition of monosodium urate crystals takes place in and around joints as serum uric acid level rise and the physiological saturation threshold for uric acid is exceeded in the body fluids.Clinical manifestations of monosodium urate crystals deposition include acute of attacks of severe pain and inflammation affecting peripheraljoints, most commonly the first metatarso-phalangeal joint.
modern lifestyle :1diet 2 loss exercise 3 night life:Due to night vigil pitta dosha gets increased and so raktadushti occurs. 
symptoms:Burning sensation, pain, joint pain, tenderness of joint, inflammation of joints, stiffness of joints. 
analgesic and other drugs may causes hyper acidity, which can be referred as pitta doshaprakop, which can increase a raktadosha. 
the present study kaishora guggulu is selected for vatarakta (gout) disease it includes guggulu, amalaki, guduchi, shunthi, haritaki, maricha, pippali, trivrit, danti, vidang, Bibhataki act on vata and Pitta,kaphajdosha helps in reducing Pain and Burning sensation, anti inflammatory, immunomodulation. which is easily available, Cost effective, palatable, reliable of patients, 
clinical method:- trial group:kaishora guggulu  500mg BD.  treatment 30 day  pt 30 
             control group:allopurinol pts-100mg-OD treatment 30 day  pt 30  


 
Close